Company Profile

RNA Nanotherapeutics LLC
Profile last edited on: 4/20/2023      CAGE: 98UK0      UEI: Z6AASCENHFA4

Business Identifier: Personalizing breast cancer treatments
Year Founded
2021
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2900 Reading Road
Cincinnati, OH 45206
   (513) 558-3017
   N/A
   rnanano.com
Location: Single
Congr. District: 01
County: Warren

Public Profile

RNA Nanotherapeutics team is working on defining and beig able to use technqiues and procedures whereby oncologists can determine the personal treating of each cancer patient.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 1 NIH $461,500
Project Title: Overcoming Breast Cancer Therapeutic Resistance by Multifunctional RNA Nanoparticles

Key People / Management

  Xiaoting Zhang -- President and Founder

  Joe Buse -- Entrepreneur in Residence,

  Marc Lemaitre -- Strategy Advisor

  Elyse Lower -- Medical Advisor

Company News

There are no news available.